335 related articles for article (PubMed ID: 9687498)
21. The glucocorticoid receptor is a key regulator of the decision between self-renewal and differentiation in erythroid progenitors.
Wessely O; Deiner EM; Beug H; von Lindern M
EMBO J; 1997 Jan; 16(2):267-80. PubMed ID: 9029148
[TBL] [Abstract][Full Text] [Related]
22. Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.
Rascle A; Ferrand N; Gandrillon O; Samarut J
Mol Cell Biol; 1996 Nov; 16(11):6338-51. PubMed ID: 8887663
[TBL] [Abstract][Full Text] [Related]
23. The v-erb A oncogene causes repression of erythrocyte-specific genes and an immature, aberrant differentiation phenotype in normal erythroid progenitors.
Schroeder C; Raynoschek C; Fuhrmann U; Damm K; Vennström B; Beug H
Oncogene; 1990 Oct; 5(10):1445-53. PubMed ID: 1979159
[TBL] [Abstract][Full Text] [Related]
24. GAR22: a novel target gene of thyroid hormone receptor causes growth inhibition in human erythroid cells.
Gamper I; Koh KR; Ruau D; Ullrich K; Bartunkova J; Piroth D; Hacker C; Bartunek P; Zenke M
Exp Hematol; 2009 May; 37(5):539-548.e4. PubMed ID: 19375645
[TBL] [Abstract][Full Text] [Related]
25. The nuclear oncogenes v-erbA and v-ets cooperate in the induction of avian erythroleukemia.
Metz T; Graf T
Oncogene; 1992 Mar; 7(3):597-605. PubMed ID: 1347919
[TBL] [Abstract][Full Text] [Related]
26. Induction of platelet-derived growth factor B/c-sis by the v-erbA oncogene in glial cells.
Iglesias T; Llanos S; López-Barahona M; Seliger B; Rodríguez-Peña A; Bernal J; Muñoz A
Oncogene; 1995 Mar; 10(6):1103-10. PubMed ID: 7700635
[TBL] [Abstract][Full Text] [Related]
27. The v-erbA oncogene blocks expression of alpha2/beta1 integrin a normal inhibitor of erythroid progenitor proliferation.
Mey A; Gandrillon O; McNagny KM; Clegg DO; Samarut J
Oncogene; 2002 Apr; 21(18):2864-72. PubMed ID: 11973646
[TBL] [Abstract][Full Text] [Related]
28. Differential and tissue-specific regulation of the multiple rat c-erbA messenger RNA species by thyroid hormone.
Hodin RA; Lazar MA; Chin WW
J Clin Invest; 1990 Jan; 85(1):101-5. PubMed ID: 2153150
[TBL] [Abstract][Full Text] [Related]
29. Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repression.
Forrest D; Muñoz A; Raynoschek C; Vennström B; Beug H
Oncogene; 1990 Mar; 5(3):309-16. PubMed ID: 1969136
[TBL] [Abstract][Full Text] [Related]
30. Targeting of N-CoR and histone deacetylase 3 by the oncoprotein v-erbA yields a chromatin infrastructure-dependent transcriptional repression pathway.
Urnov FD; Yee J; Sachs L; Collingwood TN; Bauer A; Beug H; Shi YB; Wolffe AP
EMBO J; 2000 Aug; 19(15):4074-90. PubMed ID: 10921888
[TBL] [Abstract][Full Text] [Related]
31. Induction of differentiation of avian erythroblastosis virus-transformed erythroblasts by the protein kinase inhibitor H7: analysis of the transcription factor EF1.
Nicolas RH; Partington G; Major GN; Smith B; Carne AF; Huskisson N; Goodwin G
Cell Growth Differ; 1991 Mar; 2(3):129-35. PubMed ID: 1676294
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of c-erbA proto-oncogene enhances myogenic differentiation.
Carnac G; Albagli-Curiel O; Desclozeaux M; Vandromme M; Glineur C; Bègue A; Laudet V; Bonnieu A
Oncogene; 1993 Nov; 8(11):3103-10. PubMed ID: 8414512
[TBL] [Abstract][Full Text] [Related]
33. Sarcoma and thyroid disorders: a common etiology?
Merimsky O; Issakov J; Kollender Y; Inbar M; Bickels J; Meller I
Oncol Rep; 2002; 9(4):863-9. PubMed ID: 12066223
[TBL] [Abstract][Full Text] [Related]
34. Thyroid hormone T3 acting through the thyroid hormone alpha receptor is necessary for implementation of erythropoiesis in the neonatal spleen environment in the mouse.
Angelin-Duclos C; Domenget C; Kolbus A; Beug H; Jurdic P; Samarut J
Development; 2005 Mar; 132(5):925-34. PubMed ID: 15673575
[TBL] [Abstract][Full Text] [Related]
35. The carbonic anhydrase II gene, a gene regulated by thyroid hormone and erythropoietin, is repressed by the v-erbA oncogene in erythrocytic cells.
Pain B; Melet F; Jurdic P; Samarut J
New Biol; 1990 Mar; 2(3):284-94. PubMed ID: 2126201
[TBL] [Abstract][Full Text] [Related]
36. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts.
Pereira R; Quang CT; Lesault I; Dolznig H; Beug H; Ghysdael J
Oncogene; 1999 Feb; 18(8):1597-608. PubMed ID: 10102630
[TBL] [Abstract][Full Text] [Related]
37. Transformation of erythroid progenitors by viral and cellular tyrosine kinases.
Beug H; Schroeder C; Wessely O; Deiner E; Meyer S; Ischenko ID; Hayman MJ
Cell Growth Differ; 1995 Aug; 6(8):999-1008. PubMed ID: 8547228
[TBL] [Abstract][Full Text] [Related]
38. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).
Saatcioglu F; Bartunek P; Deng T; Zenke M; Karin M
Mol Cell Biol; 1993 Jun; 13(6):3675-85. PubMed ID: 8098843
[TBL] [Abstract][Full Text] [Related]
39. V-erbA and c-erbA proteins enhance transcriptional activation by c-jun.
Sharif M; Privalsky ML
Oncogene; 1992 May; 7(5):953-60. PubMed ID: 1349165
[TBL] [Abstract][Full Text] [Related]
40. The v-erbA oncogene (review).
Thormeyer D; Baniahmad A
Int J Mol Med; 1999 Oct; 4(4):351-8. PubMed ID: 10493974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
